ST高升(000971) - 2021 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2021 was ¥187,568,549.04, a decrease of 2.08% compared to the same period last year[3] - Net profit attributable to shareholders was ¥46,204,838.21, an increase of 7,049.99% year-on-year[3] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥50,637,398.52, a decrease of 790.37% compared to the previous year[3] - The basic earnings per share for the period was ¥0.04, an increase of 3,900.00% year-on-year[3] - Total operating revenue for Q3 2021 was CNY 543,738,381.70, a decrease of 8.3% from CNY 593,069,825.06 in the same period last year[22] - Total operating costs increased to CNY 644,995,154.86, up 15.4% from CNY 558,453,340.01 in the previous year[22] - Net profit for Q3 2021 was CNY 10,923,871.20, slightly down from CNY 11,038,290.43 in Q3 2020[24] - The company reported a gross loss of CNY 95,122,273.24 in Q3 2021, compared to a profit of CNY 15,595,824.16 in the same quarter last year[23] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,157,752,274.29, a decrease of 0.15% from the end of the previous year[3] - Total assets amounted to CNY 2,157,752,274.29, a slight decrease from CNY 2,160,900,455.00 at the end of the previous quarter[20] - Total liabilities were CNY 941,265,170.68, compared to CNY 937,669,410.22 in the previous quarter[20] - The company’s equity attributable to shareholders was CNY 1,214,177,338.19, down from CNY 1,219,953,659.39 in the previous quarter[20] - The total current assets as of September 30, 2021, are RMB 1,180,068,735.31, slightly down from RMB 1,182,588,406.22 at the end of 2020[18] - Total liabilities amounted to approximately 937.67 million, a decrease of 68.50 million compared to the previous period[32] - Current liabilities totaled approximately 462.17 million, with accounts payable at approximately 165.07 million and other payables at approximately 199.10 million[32] - Non-current liabilities were approximately 475.50 million, including lease liabilities of approximately 53.35 million and estimated liabilities of approximately 446.20 million[32] Cash Flow - Cash flow from operating activities was -¥80,444,697.67, a decrease of 5.62% year-to-date[3] - Cash flow from operating activities was CNY 505,915,210.35, a decrease from CNY 518,931,261.71 in the previous year[26] - The net cash inflow from operating activities was CNY 593.75 million, compared to CNY 546.75 million in the previous year, reflecting an increase of approximately 8.5%[27] - The net cash outflow from operating activities was CNY 674.19 million, up from CNY 622.91 million year-over-year, indicating a rise of about 8.2%[27] - The net cash flow from investment activities was negative CNY 58.02 million, a significant improvement from negative CNY 117.79 million in the same period last year[28] - The company incurred cash payments for the acquisition of fixed assets and intangible assets totaling CNY 74.07 million, up from CNY 38.97 million year-over-year, reflecting an increase of about 90%[28] - The cash inflow from financing activities was CNY 5 million, with cash outflows totaling CNY 16.11 million, resulting in a net cash flow from financing activities of negative CNY 11.11 million[28] Shareholder Information - The total number of common shareholders at the end of the reporting period is 22,678[11] - Tianjin Bai Ruoke Pharmaceutical Biotechnology Co., Ltd. holds 15.12% of shares, totaling 158,550,396 shares, with 109,275,198 shares pledged[11] - Blue Ding Industrial (Hubei) Co., Ltd. holds 8.60% of shares, totaling 90,178,582 shares, with 90,000,000 shares pledged and frozen[11] Legal and Regulatory Issues - The company has ongoing legal issues related to unauthorized guarantees amounting to approximately RMB 839.64 million[14] - The company received a debt transfer notice from Beijing Bitian Wealth Investment Co., Ltd., which transferred its claims to Tianjin Bai Ruoke[15] Adjustments and Standards - The company adjusted its financial statements for the first-time implementation of new leasing standards, impacting the balance sheet items[29] - The total assets of the company amounted to CNY 2.16 billion, with a net adjustment of CNY 68.5 million due to the new leasing standards[30] - The company did not adjust prior period comparative data for the new leasing standards, maintaining original values for finance leases[34] - The report was not audited, indicating that the figures may be subject to change upon final review[35] - The report was released on October 27, 2021, providing insights into the company's financial position for Q3 2021[36]